Blood tests may unlock secrets of leukemia in seniors
NCT ID NCT07250217
First seen Dec 24, 2025 · Last updated May 09, 2026 · Updated 18 times
Summary
This study aims to identify specific epigenetic markers in the blood of elderly patients with acute myeloid leukemia (AML). Researchers will compare blood samples from 30 AML patients and a control group of healthy older adults undergoing heart surgery. The goal is to better understand the disease by analyzing DNA methylation patterns, not to provide direct treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
GHRMSA
RECRUITINGMulhouse, 68100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Groupe Hospitalier de la Région de Mulhouse et Sud Alsace
RECRUITINGMulhouse, Alsace, 68100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.